×
About 1,167 results

ALLMedicine™ Angioimmunoblastic T-cell Lymphoma Center

Research & Reviews  567 results

Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphom...
https://doi.org/10.1016/j.clml.2021.03.002
Clinical Lymphoma, Myeloma & Leukemia; Nguyen PN, Tran NTB et. al.

Apr 14th, 2021 - Studies have recently shown that RHOA mutations play a crucial role in angioimmunoblastic T-cell lymphoma (AITL) pathogenesis. We aimed to pool data from these studies to provide a comparison of clinicopathological features between the RHOA mutant...

Conditional survival and hazards of death for peripheral T-cell lymphomas.
https://doi.org/10.18632/aging.202782
Aging Gao H, Ji X et. al.

Apr 5th, 2021 - Typically, peripheral T-cell lymphoma (PTCLs) prognosis is estimated using overall survival before treatment. However, these estimates cannot show how prognosis evolves with the changing hazard rate over time. Patients (n = 650) with newly diagnos...

Outcomes and Prognostic Factors in Angioimmunoblastic T cell Lymphoma: Final Report fro...
https://doi.org/10.1182/blood.2020010387
Blood Advani R, Skrypets T et. al.

Mar 31st, 2021 - Angioimmunoblastic T-cell lymphoma (AITL) is a unique subtype of peripheral T-cell lymphoma (PTCL) with distinct clinicopathologic features and poor prognosis. We performed a subset analysis of 282 patients with AITL enrolled between 2006 and 2018...

Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic L...
https://doi.org/10.1097/PAS.0000000000001646
The American Journal of Surgical Pathology; Trimech M, Letourneau A et. al.

Mar 19th, 2021 - Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is an indolent small B-cell neoplasm that may transform into a clinically aggressive disease, namely Richter syndrome, usually as diffuse large B-cell lymphoma. Besides, CLL/SLL enc...

Angioimmunoblastic T-cell lymphoma masquerading as granulomatous lymphadenitis: Fine ne...
https://doi.org/10.1002/dc.24726
Diagnostic Cytopathology; van den Akker TA, Chen H

Feb 25th, 2021 - Fine needle aspiration (FNA) is a minimally invasive technique used in the initial diagnosis of superficial lesions, including lymphadenopathy. Its benefit in lymph node pathology, however, is highly variable, especially in heterogeneous lymphopro...

see more →

Clinicaltrials.gov  581 results

Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphom...
https://doi.org/10.1016/j.clml.2021.03.002
Clinical Lymphoma, Myeloma & Leukemia; Nguyen PN, Tran NTB et. al.

Apr 14th, 2021 - Studies have recently shown that RHOA mutations play a crucial role in angioimmunoblastic T-cell lymphoma (AITL) pathogenesis. We aimed to pool data from these studies to provide a comparison of clinicopathological features between the RHOA mutant...

Conditional survival and hazards of death for peripheral T-cell lymphomas.
https://doi.org/10.18632/aging.202782
Aging Gao H, Ji X et. al.

Apr 5th, 2021 - Typically, peripheral T-cell lymphoma (PTCLs) prognosis is estimated using overall survival before treatment. However, these estimates cannot show how prognosis evolves with the changing hazard rate over time. Patients (n = 650) with newly diagnos...

Outcomes and Prognostic Factors in Angioimmunoblastic T cell Lymphoma: Final Report fro...
https://doi.org/10.1182/blood.2020010387
Blood Advani R, Skrypets T et. al.

Mar 31st, 2021 - Angioimmunoblastic T-cell lymphoma (AITL) is a unique subtype of peripheral T-cell lymphoma (PTCL) with distinct clinicopathologic features and poor prognosis. We performed a subset analysis of 282 patients with AITL enrolled between 2006 and 2018...

Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic L...
https://doi.org/10.1097/PAS.0000000000001646
The American Journal of Surgical Pathology; Trimech M, Letourneau A et. al.

Mar 19th, 2021 - Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is an indolent small B-cell neoplasm that may transform into a clinically aggressive disease, namely Richter syndrome, usually as diffuse large B-cell lymphoma. Besides, CLL/SLL enc...

Angioimmunoblastic T-cell lymphoma masquerading as granulomatous lymphadenitis: Fine ne...
https://doi.org/10.1002/dc.24726
Diagnostic Cytopathology; van den Akker TA, Chen H

Feb 25th, 2021 - Fine needle aspiration (FNA) is a minimally invasive technique used in the initial diagnosis of superficial lesions, including lymphadenopathy. Its benefit in lymph node pathology, however, is highly variable, especially in heterogeneous lymphopro...

see more →

News  19 results

Angioimmunoblastic T-cell Lymphoma: Patient Characteristics and Survival Outcomes
https://www.mdedge.com/fedprac/avaho/article/207820/lymphoma-plasma-cell-disorders/angioimmunoblastic-t-cell-lymphoma?channel=53
Ermann DA, Vardell VA et. al.

Sep 9th, 2019 - Background: Angioimmunoblastic T-cell lymphoma (AITL) is a rare and aggressive malignancy, representing approximately 18. 5% of Peripheral T-cell lymphomas.

HDAC/HMA combo shows ‘remarkable’ activity in PTCL
https://www.mdedge.com/hematology-oncology/article/206189/t-cell-lymphomas/hdac/hma-combo-shows-remarkable-activity-ptcl?channel=303
Neil Osterweil

Aug 9th, 2019 - LUGANO, SWITZERLAND – A combination of 5-azacytidine and romidepsin showed promising activity in patients with peripheral T cell lymphomas, particularly angioimmunoblastic T-cell lymphoma (AITL) and primary cutaneous follicular helper T-cell lymph.

Cerdulatinib yields ‘encouraging’ results in CTCL, PTCL
https://www.mdedge.com/hematology-oncology/article/193975/lymphoma-plasma-cell-disorders/cerdulatinib-yields-encouraging?channel=39313
Jennifer Smith

Feb 6th, 2019 - LA JOLLA, CALIF. – The spleen tyrosine kinase/Janus kinase inhibitor cerdulatinib has demonstrated activity against relapsed and refractory T-cell lymphomas.

Combo emerges as bridge to transplant in rel/ref PTCL
https://www.mdedge.com/hematology-oncology/article/193912/lymphoma-plasma-cell-disorders/combo-emerges-bridge-transplant/page/0/1?channel=39313

Feb 5th, 2019 - Efficacy with romidepsin Among all evaluable PTCL patients in the romidepsin arm, the ORR was 59% (16/27), and the CR rate was 33% (9/27). Responses occurred in seven patients with PTCL not otherwise specified (NOS), six with angioimmunoblastic T-.

Four-drug combo shows durable responses in relapsed/refractory lymphomas
https://www.mdedge.com/hematology-oncology/article/193002/t-cell-lymphomas/four-drug-combo-shows-durable-responses-relapsed
Jennifer Smith

Jan 19th, 2019 - LA JOLLA, CALIF. — Results of a phase 1 trial suggest a four-drug combination can produce durable responses in patients with relapsed or refractory T- and B-cell lymphomas.

see more →